Official Twitter Page of the Endocrine Pathology Society and its companion journal, Endocrine Pathology #EndoPath #USCAP #EndoPathSociety #EndocrinePathology
Joined March 2017
- Tweets1.6K
- Following170
- Followers2.2K
- Likes457
Endocrine Pathology retweeted
ECP2026 in Stockholm with endocrine pathologists Christofer Juhlin, Sylvia Asa and Ozgur Mete 🇸🇪🔬
Endocrine Pathology retweeted
🇸🇪 Endocrine Pathology at #ECP2026 in Stockholm!
Monday highlights: 🧩 The Endocrine Challenge, 🏆 Best Poster Session & 🧬 Adrenal and paraganglia: are there new kids on the blocks?
From morphology to molecular diagnostics - lots to discuss!
espcongress.org/
Endocrine Pathology retweeted
An image in @EndoPath details a 40-year-old woman with a rapidly enlarging thyroid nodule and lymph node metastases. Histological analysis revealed a malignant small round blue cell tumor, leading to a diagnosis of thyroblastoma.
bit.ly/4vvlAPS
Endocrine Pathology retweeted
Research published in @EndoPath presents genetic insights from adrenal tumors in a MEN1 patient. The study identifies mutations in TP53 and NF1 linked to malignancy, raising awareness of increased cancer risk in MEN1 patients.
bit.ly/3N26OyS
Endocrine Pathology retweeted
🔬New in Endocrine Pathology!
Proteomic analysis of bilateral macronodular adrenocortical disease, a rare cause of Cushing syndrome, identifies 3 distinct protein patterns linked to pathology and genetics - opening new diagnostic perspectives.
link.springer.com/article/10…
Endocrine Pathology retweeted
@EndoPath reports on EBV-positive neuroendocrine carcinoma of the nasopharynx, a rare cancer with distinct molecular features. Whole-exome sequencing reveals high mutational burden and key mutations in TP53, APC, and PROK2.
bit.ly/4sXLF8W
Endocrine Pathology retweeted
A study in @EndoPath analyzes protein signatures in bilateral macronodular adrenocortical disease (BMAD) using LC-MS/MS. Findings reveal three distinct proteomic groups linked to microscopic and molecular characteristics.
bit.ly/3ZeR51G
Endocrine Pathology retweeted
🧬 New research in our journal!
Mismatch repair (MMR) deficiency is rare (2.2%) in pituitary neuroendocrine tumors, but reduced MMR expression is seen in specific aggressive subtypes - especially functioning corticotroph and invasive lactotroph tumors.
link.springer.com/article/10…
Endocrine Pathology retweeted
A new study compares focus quality across three whole-slide scanners for thyroid cytology! An automated Laplacian variance score helped detect out-of-focus areas, especially in 3-D cell clusters, and may support scanner choice and quality control.
link.springer.com/article/10…
Endocrine Pathology retweeted
The Endocrine Pathology Society is honored to present the 2025 Lifetime Achievement Award to Dr. Arthur S. Tischler 🎉
A pioneer in PPGL pathology whose decades of discoveries, models & mentorship shaped the field. Read more in our latest article!
link.springer.com/article/10…
Endocrine Pathology retweeted
A study in @EndoPath details an adult male with a retroperitoneal mass. Biopsy revealed atypical epithelial cells and aberrant β-catenin expression, leading to a diagnosis of pancreatoblastoma despite absent squamoid nests.
bit.ly/3Y26ulp
Endocrine Pathology retweeted
A multicenter study in @EndoPath analyzed 119 cases of medullary thyroid carcinoma (MTC) and found DLL3 expression in 89.1% of tumors, with high levels linked to larger size and aggressive features.
bit.ly/4oRKtR7
Endocrine Pathology retweeted
Actually, it doesn’t. ATCs can exhibit a squamoid or even overt squamous morphology, and according to the 2022 WHO classification, all so-called ‘thyroid squamous cell carcinomas’ should now be classified as ATC.
pubmed.ncbi.nlm.nih.gov/3528…
Endocrine Pathology retweeted
New in Endocrine Pathology:
Immunotherapy shows promise in alkylating-pretreated metastatic PanNETs, especially in TMB-high and MMR-deficient tumors.
MMRd patients had longer PFS and higher response rates, supporting routine MMR IHC and TMB testing. 🙏🏼
link.springer.com/article/10…
Endocrine Pathology retweeted
A study in @EndoPath examines the effectiveness of immunotherapy in patients with metastatic pancreatic neuroendocrine tumors (PanNETs) previously treated with alkylating agents. Key findings include progression-free survival and response rates.
bit.ly/4oUHEiQ
Endocrine Pathology retweeted
An 11-year-old with DICER1 syndrome presented with an encapsulated thyroid tumor showing follicular and morular growth. Molecular profiling revealed constitutional and somatic DICER1 variants plus CTNNB1 mutation. A tumor that did not read the textbook!
link.springer.com/article/10…
Endocrine Pathology retweeted
New in Endocrine Pathology: Diagnosing anaplastic thyroid carcinoma on core biopsy requires careful morphologic & IHC evaluation, with molecular testing guiding targeted therapy. Review highlights key pitfalls, biomarkers & treatment implications.
link.springer.com/article/10…
Endocrine Pathology retweeted
🚨 New in Endocrine Pathology!
A novel pre-op score (P-SMART) uses serum succinate, tumor size & location to predict metastatic risk in paragangliomas.
Outperforms existing models & may refine imaging + surveillance strategies.
link.springer.com/article/10…
Endocrine Pathology retweeted
Can AI spot what even expert eyes might miss? MiThyCA, a new deep learning pipeline, identifies microscopic papillary thyroid carcinoma foci swiftly and accurately from thyroid histology slides.
link.springer.com/article/10…
Endocrine Pathology retweeted
What’s in a name? New meta-analysis of DNA methylation data shows pituitary “adenomas” share more patterns with NETs than with adenomas - backing the PitNET terminology and reshaping how we classify these tumors. #PathTwitter #EndocrinePath
link.springer.com/article/10…
